Article | February 20, 2005

Full Article: Ion Mobility Spectrometry for Determination of Active Drug in Blinded Dosage Forms

Source: Smiths Detection
Clinical trials are an important part of the drug product development process. While the physical attributes of commercially available tablets and capsules may be useful for identification of drug products, the unique appearance of these dosage forms can be problematic in clinical trials, especially when the studies collect subjective data...

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online